Biomarkers /

THADA

Back to Biomarkers List

Overview

Location [1]
2p21
Protein [2]
Thyroid adenoma-associated protein
Synonyms [1]
ARMC13, GITA

THADA is altered in 3.76% of all cancers with breast invasive ductal carcinoma, breast invasive lobular carcinoma, breast neoplasm, mixed lobular and ductal breast carcinoma, and mucinous breast carcinoma having the greatest prevalence of alterations [3].

THADA GENIE Cases - Top Diseases

The most common alterations in THADA are THADA Amplification (0.66%), THADA R923Q (0.12%), THADA G390R (0.08%), THADA V1129M (0.08%), and THADA A1237S (0.04%) [3].

THADA GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.